United Therapeutics / UTHR
About United Therapeutics
1110 Spring St., Silver Spring, Md. 20910
www.unither.com
| 301-608-9292
| Founded: 1996
Industry: Biotechnology | Category: Public Companies
United Therapeutics develops medicines for chronic vascular and infectious diseases and for cancer. Its main product, Remodulin, is a drug for pulmonary arterial hypertension, a rare condition characterized by dangerously high blood pressure in the arteries between the heart and lungs. The current formulation needs to be constantly infused into the body either intravenously or via an injection under the skin. The company is working on an inhalable version and received some encouraging test results last year.
President and COO: Roger Jeffs
2007 Financial Data
Revenues: $210,943,000 | Net Income: $19,859,000Asssets: $587,020,000 | Earnings Per Share: $0.88
Stockholder Equity: $295,790,000 | Annual Dividend: $0.00
Total employees: 288 | Local employees: 93
Company Leadership
| Christopher Causey | Director |
| Raymond Dwek | Director |
| R. Paul Gray | Director |
| Roger A. Jeffs | President, Chief Operating Officer and Director |
| Raymond C. Kurzweil | Director |
| Christopher Patusky | Vice Chairman and Lead Director |
| Martine Rothblatt | Founder, Chairman and Chief Executive Officer |
| Louis Sullivan | Director |
| Martine A. Rothblatt | Chairman and Chief Executive Officer |
| Roger Jeffs Ph.D. | President and Chief Operating Officer |
| Paul A. Mahon J.D. | Executive Vice President for Strategic Planning, General Counsel, and Secretary |
Source: Compensation data provided by Equilar, Inc..
| Martine A. Rothblatt Chairman and Chief Executive Officer | $24,995,900 Salary: $767,100 |
| Roger Jeffs Ph.D. President and Chief Operating Officer | $4,052,100 Salary: $668,800 |
| Paul A. Mahon J.D. Executive Vice President for Strategic Planning, General Counsel, and Secretary | $2,978,600 Salary: $578,800 |
Did You Know
IN THE BLACK: United Therapeutics is one of the few local biotechnology companies that make money; 2007 was the sixth straight year in which its revenue grew by more than 30 percent.
